Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:00 AM
Ignite Modification Date:
2025-12-25 @ 12:00 AM
NCT ID:
NCT02700958
Eligibility Criteria:
Inclusion Criteria:
* Age greater than 18 years, no upper age limit
* Patients with stable coronary artery disease (II - III class according to the Canadian Cardiovascular Society) hospitalized for coronarography or with lower extremity arterial disease hospitalized for angiography
* Written informed consent
Exclusion Criteria:
* Pregnancy
* Age less than 18 years
* eGFR \< 30 ml/min/1,73 m2
* Simultaneous participation in an other clinical trial
* Coexisting pathology of the upper-limbs limiting the use of the cuff (bilateral amputee, recent trauma, chronic ulcers, significant upper limb peripheral atherosclerosis (radial pulse not palpable on either side))
* Malignant tumor (in remission less than 5 years or ongoing treatment)
* Documented allergic reaction to iodinated contrast agent
* Acute infection (body temperature 38 degrees Celsius or higher, c reactive protein 50mg/L or higher)
* Cardiac rhythm abnormalities (atrial fibrillation, frequent supraventricular premature complexes)
* Documented myocardial infarction within 30 days
* Inability to understand the instructions of the study
* Vascular surgery in axillary region
* Unable to lie supine for 40 minutes
* Home oxygen treatment
* Documented upper limb deep vein thrombosis
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02700958
Study Brief:
Protocol Section:
NCT02700958